Standpoint Research Starts Coherus Biosciences (CHRS) at Buy
Tweet
Share
E-mailGet Alerts CHRS Hot Sheet
Price: $1.33 -0.75%
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 8
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 8
Join SI Premium – FREE
Standpoint Research initiates coverage on Coherus Biosciences (NASDAQ: CHRS) with a Buy rating and a price target of $40.00.
For an analyst ratings summary and ratings history on Coherus Biosciences click here. For more ratings news on Coherus Biosciences click here.
Shares of Coherus Biosciences closed at $28.10 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts Faraday Copper Corp (FDY:CN) (CPPKF) at Buy
- Guggenheim Starts CalciMedica (CALC) at Buy
- B.Riley Starts Alpha Cognition Inc (ACOG) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Standpoint ResearchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
